|
🐜
|
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV
31 auth.
Alexey Stukalov,
V. Girault,
Vincent Grass,
Valter Bergant,
Ozge Karayel,
C. Urban,
Darya A. Haas,
Yiqi Huang,
L. Oubraham,
Anqi Wang,
Sabri Hamad,
A. Piras,
M. Tanzer,
Fynn M. Hansen,
T. Engleitner,
...
Maria Reinecke,
Maria Reinecke,
T. Lavacca,
R. Ehmann,
R. Wölfel,
J. Jores,
B. Kuster,
B. Kuster,
U. Protzer,
R. Rad,
J. Ziebuhr,
V. Thiel,
Pietro Scaturro,
Pietro Scaturro,
M. Mann,
A. Pichlmair
|
9 |
2020 |
9
🐜
|
|
🐜
|
ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion
17 auth.
Georg Jocher,
Vincent Grass,
Sarah K Tschirner,
L. Riepler,
Stephan Breimann,
Tugberk Kaya,
M. Oelsner,
M. S. Hamad,
Laura I. Hofmann,
C. Blobel,
...
C. Schmidt‐Weber,
O. Gokce,
C. Jakwerth,
Jakob Trimpert,
J. Kimpel,
A. Pichlmair,
S. Lichtenthaler
|
6 |
2022 |
6
🐜
|
|
🐜
|
Data, Reagents, Assays and Merits of Proteomics for SARS-CoV-2 Research and Testing
11 auth.
J. Zecha,
Chien-Yun Lee,
Florian P. Bayer,
C. Meng,
Vincent Grass,
J. Zerweck,
...
K. Schnatbaum,
T. Michler,
A. Pichlmair,
C. Ludwig,
B. Kuster
|
6 |
2020 |
6
🐜
|
|
🐜
|
Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread
17 auth.
Shubhankar Ambike,
Cho-Chin Cheng,
M. Feuerherd,
S. Velkov,
Domizia Baldassi,
S. Afridi,
D. Porras-Gonzalez,
Xin Wei,
Philipp Hagen,
N. Kneidinger,
...
M. Stoleriu,
Vincent Grass,
G. Burgstaller,
A. Pichlmair,
Olivia M. Merkel,
C. Ko,
T. Michler
|
5 |
2021 |
5
🐜
|
|
🐜
|
Disruption of disulfides within RBD of SARS‐CoV‐2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs
12 auth.
Mateja Manček-Keber,
Iva Hafner-Bratkovič,
D. Lainšček,
M. Benčina,
Tea Govednik,
S. Orehek,
...
Tjaša Plaper,
Vid Jazbec,
Valter Bergant,
Vincent Grass,
A. Pichlmair,
R. Jerala
|
5 |
2021 |
5
🐜
|
|
🐜
|
Cross-species analysis of viral nucleic acid interacting proteins identifies TAOKs as innate immune regulators
18 auth.
Friederike L. Pennemann,
A. Mussabekova,
C. Urban,
Alexey Stukalov,
L. L. Andersen,
Vincent Grass,
T. Lavacca,
C. Holze,
L. Oubraham,
Yasmine Benamrouche,
...
E. Girardi,
Rasha E. Boulos,
R. Hartmann,
G. Superti-Furga,
M. Habjan,
J. Imler,
C. Meignin,
A. Pichlmair
|
4 |
2021 |
4
🐜
|
|
🐜
|
Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection
32 auth.
K. Wagner,
L. Mateyka,
S. Jarosch,
Vincent Grass,
Simone Weber,
Kilian Schober,
Monika Hammel,
Teresa Burrell,
B. Kalali,
H. Poppert,
Henriette Beyer,
Sophia E Schambeck,
S. Holdenrieder,
Andrea Strötges-Achatz,
V. Haselmann,
...
M. Neumaier,
J. Erber,
Alina Priller,
Sarah Yazici,
H. Roggendorf,
M. Odendahl,
T. Tonn,
A. Dick,
K. Witter,
H. Mijočević,
U. Protzer,
P. Knolle,
A. Pichlmair,
C. Crowell,
M. Gerhard,
E. D’Ippolito,
D. Busch
|
4 |
2021 |
4
🐜
|
|
🐜
|
Attenuation of SARS‐CoV‐2 replication and associated inflammation by concomitant targeting of viral and host cap 2'‐O‐ribose methyltransferases
29 auth.
Valter Bergant,
Shintaro Yamada,
Vincent Grass,
Y. Tsukamoto,
T. Lavacca,
Karsten Krey,
Maria-Teresa Mühlhofer,
S. Wittmann,
A. Ensser,
A. Herrmann,
Anja vom Hemdt,
Yuriko Tomita,
S. Matsuyama,
T. Hirokawa,
Yiqi Huang,
...
A. Piras,
C. Jakwerth,
M. Oelsner,
Susanne E. Thieme,
A. Graf,
S. Krebs,
H. Blum,
B. Kümmerer,
Alexey Stukalov,
C. Schmidt‐Weber,
Manabu Igarashi,
T. Gramberg,
A. Pichlmair,
H. Kato
|
4 |
2022 |
4
🐜
|
|
🐜
|
Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein
15 auth.
Hristo L. Svilenov,
Julia Sacherl,
A. Reiter,
Lisa S. Wolff,
Cho-Chin Cheng,
Marcel Stern,
Vincent Grass,
F. Wachs,
Nicole Simonavicius,
S. Pippig,
...
F. Wolschin,
O. Keppler,
J. Buchner,
C. Brockmeyer,
U. Protzer
|
4 |
2021 |
4
🐜
|
